Simplex Trading’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.04K Sell
200
-1,400
-88% -$60.3K ﹤0.01% 7544
2025
Q4
$81K Sell
1,600
-1,500
-48% -$53.3K ﹤0.01% 5200
2025
Q3
$90K Sell
3,100
-41,700
-93% -$964K ﹤0.01% 5877
2025
Q2
$1.05M Buy
44,800
+37,100
+482% +$834K ﹤0.01% 2723
2025
Q1
$184K Buy
7,700
+100
+1% +$3.21K ﹤0.01% 4440
2024
Q4
$321K Buy
7,600
+400
+6% +$17.7K ﹤0.01% 3999
2024
Q3
$318K Buy
7,200
+1,100
+18% +$41.7K ﹤0.01% 4068
2024
Q2
$220K Sell
6,100
-16,400
-73% -$651K ﹤0.01% 4574
2024
Q1
$970K Buy
22,500
+22,400
+22,400% +$798K ﹤0.01% 3154
2023
Q4
$1K Buy
+100
New +$1.27K ﹤0.01% 8604
2023
Q3
Sell
-77,400
Closed -$1.24M 9916
2023
Q2
$1.24M Buy
77,400
+70,300
+990% +$635K ﹤0.01% 2392
2023
Q1
$55K Buy
+7,100
New +$54.8K ﹤0.01% 5825

Other funds holding VERA

Simplex Trading's VERA Position: Q1 2026 in Review

Simplex Trading opened a new position in Vera Therapeutics (VERA) in Q1 2026: 191 shares worth $7.68K. The stake represents ﹤0.01% of the portfolio and ranks #7579 among its holdings. This is a return to the name: Simplex Trading previously reported a position in VERA as recently as Q4 2024.

Simplex Trading first reported a position in VERA in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.13M in Q2 2023. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Simplex Trading held 191 shares of Vera Therapeutics worth $7.68K as of Q1 2026.
  • Vera Therapeutics was a new Simplex Trading position in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7579 holding.
  • Simplex Trading first reported a position in Vera Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Simplex Trading's Vera Therapeutics position peaked at $1.13M in Q2 2023.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.